<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The early molecular detection of the <z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> transition may enhance the strength of diagnosis in the case of colonic biopsies </plain></SENT>
<SENT sid="1" pm="."><plain>Our aims were to identify characteristic transcript sets in order to develop diagnostic <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression patterns for objective classification of benign and malignant colorectal diseases and to test the classificatory power of these markers on an independent sample set </plain></SENT>
<SENT sid="2" pm="."><plain>METHODOLOGY/PRINCIPAL FINDINGS: <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and <z:mpath ids='MPATH_270'>adenoma</z:mpath> specific transcript sets were identified using HGU133plus2 microarrays and 53 biopsies (22 CRC, 20 <z:mpath ids='MPATH_270'>adenoma</z:mpath> and 11 <z:mpath ids='MPATH_458'>normal</z:mpath>) </plain></SENT>
<SENT sid="3" pm="."><plain>Ninety-four independent biopsies (27 CRC, 29 <z:mpath ids='MPATH_270'>adenoma</z:mpath> and 38 <z:mpath ids='MPATH_458'>normal</z:mpath>) were analyzed on microarrays for testing the classificatory power of the discriminatory genes </plain></SENT>
<SENT sid="4" pm="."><plain>Array real-time PCR validation was done on 68 independent samples (24 CRC, 24 <z:mpath ids='MPATH_270'>adenoma</z:mpath> and 20 <z:mpath ids='MPATH_458'>normal</z:mpath>) </plain></SENT>
<SENT sid="5" pm="."><plain>A set of 11 transcripts (including CXCL1, CHI3L1 and GREM1) was determined which could correctly discriminate between high-grade dysplastic <z:mpath ids='MPATH_270'>adenoma</z:mpath> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples by 100% sensitivity and 88.9% specificity </plain></SENT>
<SENT sid="6" pm="."><plain>The discriminatory power of the marker set was proved to be high on independent samples in both microarray and RT-PCR analyses </plain></SENT>
<SENT sid="7" pm="."><plain>95.6% of original and 94.1% of cross-validated samples was correctly classified in discriminant analysis </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS/SIGNIFICANCE: The identified transcripts could correctly characterize the <z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> transition in biopsy samples, also on a large independent sample set </plain></SENT>
<SENT sid="9" pm="."><plain>These markers can establish the basis of gene expression based diagnostic classification of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Diagnostic RT-PCR cards can become part of the automated routine procedure </plain></SENT>
</text></document>